MiNK Therapeutics, Inc.INKTNASDAQ

Revenue (LTM)

Net Income (LTM)

$-11M

+52.0% YoY

Free Cash Flow

$-10M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	-0	-0↓41.6%	-0↓56.2%	-0↓68.1%	-0↓5.3%
Operating Income	-11	-19↓72.3%	-31↓66.3%	-23↑25.9%	-11↑53.5%
Net Income	-16	-30↓86.1%	-28↑7.4%	-22↑19.8%	-11↑52.0%
EBITDA	-14	-28↓101.6%	-28↓0.6%	-22↑20.2%	-11↑52.5%
EPS Diluted	-4.91	-9.03↓83.9%	-8.31↑8.0%	-6.54↑21.3%	-2.80↑57.2%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	3	39↑1345.1%	20↓49.5%	3↓82.9%	5↑35.9%
Total Current Assets	4	40↑1014.0%	20↓48.5%	4↓82.4%	5↑38.6%
Total Assets	5	40↑783.4%	21↓46.6%	5↓78.8%	6↑25.7%
Total Current Liabilities	14	16↑15.8%	13↓23.0%	11↓10.1%	7↓39.0%
Total Liabilities	58	16↓71.8%	22↑32.8%	23↑3.4%	25↑11.9%
Total Equity	-54	24↑144.1%	-0↓101.7%	-18↓4399.2%	-20↓8.5%
Total Debt	44	0	0	0	5
Net Debt	41	-39↓194.5%	-20↑49.5%	-3↑82.9%	0↑110.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-8	-13↓53.8%	-19↓47.1%	-16↑16.5%	-10↑39.4%
Capital Expenditure	-0	-0↓161.5%	-0↓0.4%	-0↑70.6%	-0↑100.0%
Free Cash Flow	-8	-13↓55.1%	-19↓46.2%	-16↑17.2%	-10↑39.7%
Stock-Based Comp	0	2↑1886.5%	3↑73.5%	4↑27.5%	2↓53.1%
Net Change in Cash	2	36↑1413.2%	-19↓153.2%	-16↑15.5%	1↑107.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance